Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH A NONSURGICAL FRACTURE OF THE LOWER EXTREMITY IMMOBILISED IN A BELOW-KNEE PLASTER CAST.

Trial Profile

PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH A NONSURGICAL FRACTURE OF THE LOWER EXTREMITY IMMOBILISED IN A BELOW-KNEE PLASTER CAST.

Status: Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 24 Aug 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fondaparinux sodium (Primary) ; Nadroparin calcium (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Therapeutic Use
  • Acronyms PROTECT

Most Recent Events

  • 13 Feb 2018 According to results published in the Injury - International Journal of the Care of the Injured, between April 2009 and December 2015, 467 patients were enrolled.
  • 15 Dec 2012 Planned End Date changed from 1 Apr 2011 to 1 Apr 2013 as reported by ClinicalTrials.gov.
  • 23 Apr 2009 New source identified and integrated (Netherlands Trial Register record NTR1733).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top